PlushCare vs Ro Health for GLP-1 Weight Loss: Primary Care vs Dedicated Program
An independent, side-by-side comparison of PlushCare and Ro for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
PlushCare
Starting at $99/mo vs $149/mo
Most Medications
PlushCare
2 medications vs 2
Best for Beginners
Ro
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | PlushCare | Ro | Savings |
|---|---|---|---|
| Semaglutide | $99/monthly | $149/monthly | Save $50/mo with PlushCare |
| Tirzepatide | Not offered | $299/monthly | Only at Ro |
Pros and Cons
PlushCare
- Backed by publicly traded Accolade
- Insurance-based model
- Video consultations with licensed physicians (not async questionnaire reviews)
- Prescriptions filled at your own pharmacy
- Can manage related health conditions in the same visit (primary care model)
- Available in all 50 states
- No compounded medications offered
- Generalist physicians, not obesity medicine specialists
- Low membership cost but consultation fees add up without insurance
- Not focused on weight loss
- No proprietary coaching, behavioral program, or weight-loss-specific support
Ro
- Competitive compounded semaglutide pricing (from $149/mo)
- Large established platform with millions of patients
- Free ongoing provider messaging
- Body program includes metabolic health coaching
- No video consultations — async only
- No lab testing included
- Only offers GLP-1 weight loss medications
- Compounded medications not FDA-approved as finished products
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 15, 2026
PlushCare vs Ro Health for GLP-1 Weight Loss (2026)
PlushCare and Ro serve different patient archetypes seeking GLP-1 medications. PlushCare is a primary care telehealth platform — patients get GLP-1 through the same doctor who manages their blood pressure and annual physical, typically through insurance. Ro is a dedicated weight loss program — purpose-built for GLP-1 prescribing with coaching, behavioral support, and its own pharmacy network. The choice between them depends primarily on whether insurance access or program depth is the priority.
Quick Comparison
| PlushCare | Ro Health (Body) | |
|---|---|---|
| Platform type | Primary care telehealth | Dedicated weight loss program |
| Visit cost | ~$15–20/visit (with insurance) | ~$149–199/month (all-in) |
| GLP-1 prescription | Yes — via insurance prescription | Yes — compounded or brand-name |
| Insurance acceptance | Yes — broad insurance acceptance | No — primarily cash-pay |
| Compounded GLP-1 | Not primary offering | Yes |
| Brand-name GLP-1 | Via insurance prescription | Yes — Ro pharmacy |
| Coaching / behavioral support | Not included | Yes — weight loss coaching |
| Ongoing weight management visits | Separate billable visits | Included in program |
| Lab testing | Insurance-covered lab orders | Included in program |
| Continuity of care | Assigned PCP; long-term relationship | Weight loss focused; less PCP continuity |
| Scope of care | All primary care needs | Weight loss only |
PlushCare: Primary Care as the GLP-1 Access Path
PlushCare is a full-service primary care telehealth platform. Patients see a primary care physician for all health needs — and that physician can prescribe GLP-1 medications as part of a comprehensive care relationship. Insurance accepted broadly means most patients pay $15–20/visit rather than cash-pay monthly fees.
How PlushCare GLP-1 prescribing works:
- Schedule a visit with a PlushCare PCP (available same-day or next-day)
- Discuss weight management as a clinical need; physician evaluates eligibility
- Prescription written for brand-name GLP-1 (Wegovy, Zepbound); prior authorization initiated
- Pharmacy fills prescription; insurance covers medication or prior auth needed
- Follow-up visits as needed (each visit billed separately to insurance)
PlushCare strengths:
- Insurance covers visits — typically ~$15–20 copay
- Same PCP manages all health needs including GLP-1 — continuity of care
- Insurance prescription pathway for brand-name GLP-1 (if approved)
- No large upfront program fee
- Access to full primary care services beyond weight management
PlushCare limitations:
- No program structure, coaching, or behavioral support included
- Prior authorization for GLP-1 may take weeks; denied without specialist support
- Each follow-up is a separate visit (another copay)
- No access to compounded GLP-1 (lower-cost option)
- Weight management is not a specialty — less expertise than dedicated obesity programs
Ro Health: Dedicated Program with Cash-Pay Structure
Ro's Body weight loss program provides comprehensive GLP-1 care: prescribing, pharmacy (Ro Pharmacy), behavioral coaching, and medication management, all within a dedicated weight management context. The monthly fee covers everything — patients pay one amount and get an integrated experience.
Ro strengths:
- Dedicated weight loss program with structured coaching alongside medication
- Ro Pharmacy provides both compounded and brand-name GLP-1 access
- Lab panel included at intake
- Monthly fee covers prescribing, coaching, and pharmacy services
- No separate visit copays once enrolled
Ro limitations:
- No insurance — entirely cash-pay
- ~$149–199/month regardless of visit frequency
- Weight loss only — no primary care relationship for other health needs
- Compounding regulatory risk affects medication availability
The Insurance Question: The Key Decision Factor
| Patient Scenario | Better Choice | Reason |
|---|---|---|
| Has insurance that covers GLP-1 visits | PlushCare | Visits ~$15–20 copay; prescription through insurance |
| Has insurance, GLP-1 prior auth pending | PlushCare | PCP can initiate and document prior auth |
| Has insurance, prior auth denied repeatedly | Consider Ro + separate appeal | PlushCare doesn't specialize in appeals |
| No insurance, paying cash | Ro | Dedicated program at fixed monthly cost is more structured |
| Wants coaching alongside medication | Ro | PlushCare doesn't offer weight loss behavioral support |
| Has complex health needs alongside obesity | PlushCare | PCP manages all conditions together |
Cost Analysis
| Scenario | PlushCare (Annual) | Ro (Annual) |
|---|---|---|
| GLP-1 covered by insurance | ~$240 (visits) + copays for medication | ~$1,788 (program) + medication not included |
| GLP-1 not covered, compounded cash-pay | ~$240 (visits) + |
~$1,788 (program includes compounded med in some tiers) |
| Brand-name GLP-1, full cash-pay | ~$240 + ~$10,800 (Wegovy MSRP) = prohibitive | ~$1,788 + ~$3,600 (Ro brand pricing) |
If insurance covers GLP-1 at any level, PlushCare is dramatically cheaper for visits. The medication cost is the dominant variable — if covered, PlushCare wins on total cost; if not covered, Ro's all-in structure is more predictable.
Continuity of Care: A Real Advantage for PlushCare
PlushCare assigns patients to a primary care physician for ongoing care. Over time:
- Your PCP knows your full medical history
- GLP-1 management integrates with diabetes, blood pressure, thyroid, and other care
- Annual labs, preventive care, and GLP-1 monitoring happen in one relationship
Ro provides excellent weight loss care but ends the relationship when the weight loss program concludes — there is no long-term primary care infrastructure. Patients with complex medical needs benefit from the PCP continuity that PlushCare provides.
Related Resources
- PlushCare Weight Loss Review — full program review
- Ro Health Review — full program review
- PlushCare vs Henry Meds GLP-1 — PlushCare vs dedicated low-cost option
- GLP-1 Insurance Denial FAQ — navigating coverage denials
- Best GLP-1 Programs with Insurance Navigation — full ranking
Related Guides
Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know
Complete guide to aleniglipron, Structure Therapeutics' investigational oral GLP-1 showing 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II — the highest weight loss reported for any oral GLP-1 to date. Only 3.7% discontinuation rate. Phase 3 expected H2 2026, with earliest FDA approval in 2028 or later.
Read guide →Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked
Every major GLP-1 weight loss program ranked — real pricing, clinical models, and honest assessments. No provider paid for placement.
Read guide →